The effect of magnesium sulfate on hemodynamic changes in patients undergoing laparoscopic cholecystectomy

Phase 2

• Conditions: aparoscopic cholecystectomy.; Cholelithiasis, Cholecystitis, Other diseases of gallbladder; k80, k81,

• Registration Number: IRCT2016022716612N6
• Lead Sponsor: Vice chancellor for research, Ardabil University Of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients of both genders who referred to Imam Khomeini Hospital Of Ardabil for laparoscopic cholecystectomy (age range: 18-70 years).
Exclusion criteria: Allergy to magnesium sulfate? hypermagnesemia? hypertension? morbid obesity? and severe hepatic, renal, endocrine, and cardiac dysfunction

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure changes. Timepoint: Basic vital signs, before laryngoscopy, after endotracheal intubation (in 1-5 minute intervals), before carbon dioxide insufflation, 5 minutes after carbon dioxide insufflation, 15 minutes after carbon dioxide insufflation, 30 minutes after carbon dioxide insufflation. Method of measurement: In mmHg, with barometer.;Heart rate changes. Timepoint: Basic vital signs, before laryngoscopy, after endotracheal intubation (in 1-5 minute intervals), before carbon dioxide insufflation, 5 minutes after carbon dioxide insufflation, 15 minutes after carbon dioxide insufflation, 30 minutes after carbon dioxide insufflation. Method of measurement: Counting heart beats.